Use of disease-modifying antirheumatic drugs in patients with psoriatic arthritis

Joint Bone Spine

Volumn 69, Issue 3, 2002, Pages 275-281

  Marguerie, Laurent ^a,b   Flipo, René Marc ^b   Grardel, Bruno ^c   Beaurain, Didier ^d   Duquesnoy, Bernard ^b   Delcambre, Bernard ^b  

^a Institut Calot Helio Marin   (France)

^b LILLE UNIVERSITY HOSPITAL   (France)

^c Cabinet de Dermatologie   (France)

^d Cabinet De Rhumatologie   (France)

Author keywords

Disease modifying antirheumatic drugs; Psoriatic arthritis; Second line treatment; Treatment

Indexed keywords

ALLOCHRYSINE; AZATHIOPRINE; CYCLOSPORIN; GOLD; HYDROXYCHLOROQUINE; METHOTREXATE; PENICILLAMINE; SALAZOSULFAPYRIDINE; TIOPRONIN; ANTIRHEUMATIC AGENT; DRUG DERIVATIVE; GLUCOSAMINE; ORGANOGOLD COMPOUND;

ADOLESCENT; ADULT; AGED; ARTICLE; CLINICAL PRACTICE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE EXACERBATION; DRUG EFFICACY; DRUG TOLERABILITY; DRUG WITHDRAWAL; DYSPEPSIA; FEMALE; HUMAN; HYPERTENSION; LUNG DISEASE; MAJOR CLINICAL STUDY; MALE; PRURITUS; PSORIATIC ARTHRITIS; RETROSPECTIVE STUDY; RISK BENEFIT ANALYSIS; STOMATITIS; TREATMENT OUTCOME; DRUG COMBINATION; MIDDLE AGED;

ADOLESCENT; ADULT; AGED; ANTIRHEUMATIC AGENTS; ARTHRITIS, PSORIATIC; DRUG COMBINATIONS; FEMALE; GLUCOSAMINE; HUMANS; HYDROXYCHLOROQUINE; MALE; METHOTREXATE; MIDDLE AGED; ORGANOGOLD COMPOUNDS; RETROSPECTIVE STUDIES; SULFASALAZINE; TREATMENT OUTCOME;

EID: 0035991126     PISSN: 1297319X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1297-319X(02)00396-2     Document Type: Article

References (61)

1. Therapy for psoriatic arthritis: Sometimes a conflict for psoriasis
2. The incidence of arthropathy in a ten-year series of psoriasis cases
3. Psoriatic arthritis: A clinical, immunological and HLA study of 100 patients
4. Treatment of psoriatic arthritis
5. Les thérapeutiques du rhumatisme psoriasique
6. Methotrexate therapy in psoriatic arthritis
7. Randomized, double-blind, placebo-controlled trial of low-dose pulse methotrexate in psoriatic arthritis
8. Sulfasalazine in the treatment of spondylarthropathy: A randomized, multicenter, double-blind, placebo-controlled study
9. Sulphasalazine in psoriatic arthritis: A randomized multicentre, placebo-controlled study
10. Comparison of sulphasalazine and placebo in the treatment of psoriatic arthritis
11. Sulphasalazine in psoriatic arthritis: A double-blind placebo-controlled study
12. Sulphasalazine in the management of psoriatic arthritis
13. Sulphasalazine therapy for psoriatic arthritis: A double blind, placebo controlled trial
14. Termination of disease-modifying drugs in psoriatic arthritis: Study of 109 courses of treatment
15. Long-term therapy of psoriatic arthritis: Intramuscular gold or methotrexate?
16. Termination of disease modifying antirheumatic drug in psoriatic arthritis
17. Critères de classification des spondylarthropathies
18. The European Spondylarthropathy Study Group preliminary criteria for the classification of spondylarthropathy
19. The comparative efficacy and toxicity of second-line drug in rheumatoid arthritis. Results of two meta-analyses
20. The psoriatic arthritis metaanalysis study group. Psoriatic arthritis: A quantitative overview of therapeutic options
21. The use of sulfasalazine in psoriatic arthritis: A clinic experience
22. Chrysotherapy in psoriatic arthritis. Efficacy and toxicity compared to rheumatoid arthritis
23. Gold in psoriatic arthropathy
24. Psoriatic arthritis. Long-term treatment with auranofin
25. Long-term experience with oral gold in rheumatoid arthritis and psoriatic arthritis
26. Long-term experience with oral gold in psoriatic arthritis
27. Clinical response to auranofin in patients with psoriatic arthritis
28. Exacerbation of psoriasis by chrysotherapy
29. The Auranofin Cooperating Group: A double-blind placebo controlled study of auranofin in patients with psoriatic arthritis
30. A multicentre double-blind comparison of auranofin, intramuscular gold thiomalate and placebo in patients with psoriatic arthritis
31. Psoriatic arthritis: A comparative study of rheumatoid arthritis and arthritis associated with psoriasis
32. Therapeutic suppression of tissue reactivity II. Effect of aminopterin in rheumatoid arthritis and psoriasis
33. Amethopterin (methotrexate) in connective tissue disease- psoriasis and polyarthritis
34. Le rhumatisme psoriasique. Traitement par le méthotrexate
35. Methotrexate in psoriatic arthritis: A retrospective study
36. Methotrexate treatment of psoriatic arthritis
37. Psoriatic arthritis: Clinical response and side effects to methotrexate therapy
38. Methotrexate in psoriatic arthrtitis
39. Long-term methotrexate therapy in psoriatic arthritis: Clinical and radiological outcome
40. Life-table analysis of cyclosporin A treatment in psoriatic arthritis: Comparison with other disease-modifying antirheumatic drugs
41. Chloroquine therapy in psoriatic arthritis
42. Psoriatic arthritis: A placebo-controlled study of treatment with cyclosporin A and azathioprine
43. Cyclosporin A for psoriasis
44. Generalized pustular psoriasis (von Zumbusch) responding to cyclosporin A
45. Cyclosporin for psoriasis: Beneficial effect in refractory skin and joint disease
46. Cyclosporine in the treatment of psoriatic arthritis
47. Cyclosporin A. in psoriatic arthritis: An open study
48. Low-dose cyclosporin A in psoriatic arthritis: Relation between soluble interleukin-2 response to therapy
49. Psoriatic arthritis treated with cyclosporin A
50. Therapeutic efficacy of oral low-dose cyclosporin A in severe psoriatic arthritis
51. Cyclosporin-A benefits both skin and joints disease in psoriatic arthritis
52. Anti-inflammatory efficacy of low-dose cyclosporin A in psoriatic arthritis: A prospective multicentre study
53. Comparison of cyclosporin A and methotrexate in the treatment of psoriatic: A one-year prospective study
54. Renal biopsy findings in long-term cyclosporin treatment of psoriasis
55. A double-blind controlled evaluation of azathioprine treatment in rheumatoid arthritis and psoriatic arthritis
56. Traitement de la polyarthrite psoriasique par l'azathioprine
57. Rhumatisme psoriasique grave. Traitement par azathioprine. A propos de onze cas
58. D-penicillamine and psoriatic arthropathy
59. Notre expérience du traitement du rhumatisme psoriasique par le D-pénicillamine
60. Psoriatic arthritis treated with oral colchicine
61. Therapeutic value of colchicine in the treatment of patients with psoriatic arthritis